May 28, 2020
Chimeron Bio and George Mason University’s National Center for Biodefense and Infectious Diseases Partner to Develop a Coronavirus (COVID-19) Vaccine using ChaESARTM Technology
Collaboration will test pre-clinical efficacy and safety of vaccine pipeline including COVID-19 and other coronaviruses PHILADELPHIA & FAIRFAX, Va.–(BUSINESS WIRE)–Chimeron…